Abstract:Objective To observe the myocardial protection effect of single high loading dose of 80 mg Atorvastatin before percutaneous coronary intervention (PCI) in patients accepting chronic Statin treatment for stable angina pectoris (SAP). Methods A total of 85 SAP patients who had received long-term Statin therapy were randomly assigned into conventional-dose group (given 20 mg Atorvastatin) and load-dose group (given 80 mg Atorvastatin). The patients received intensive pretreatment of Atorvastatin within 8-12 h before PCI. The changes of postoperative creatine kinase isoenzyme (CK-MB), cardiac troponin T (cTnT) and high-sensitivity C-reactive protein (hs-CRP) were observed 8 h and 24 h after PCI. Results In the conventional-dose group, the levels of CK-MB, cTnT and hs-CRP significantly increased at 8 h and 24 h after PCI compared with the preoperative levels. In the loading-dose group, the levels of CK-MB, cTnT and hs-CRP significantly increased at 24 h after PCI compared with the preoperative levels. In the loading-dose group, the levels of CK-MB, cTnT and hs-CRP significantly decreased at 24 h after PCI compared with the conventional-dose group. Conclusions Single high loading dose of 80 mg Atorvastatin given prior to PCI has myocardial protection in patients with stable angina pectoris receiving chronic Statin treatment.